Idiotypic vaccination in B-cell malignancies
- 1 October 1997
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 3 (10) , 435-441
- https://doi.org/10.1016/s1357-4310(97)89745-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- IMMUNOREGULATORY MECHANISMS IN MULTIPLE MYELOMAHematology/Oncology Clinics of North America, 1997
- Cytokines, tumour-cell death and immunogenicity: a question of choiceImmunology Today, 1997
- Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytomaEuropean Journal of Immunology, 1996
- Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsNature Medicine, 1996
- Idiotypic DNA Vaccines Against B‐cell LymphomaImmunological Reviews, 1995
- T Cells in Multiple Myeloma: Is This a Reliable Population to Count on as Antitumor Effector Cells?Leukemia & Lymphoma, 1995
- Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivoEuropean Journal of Immunology, 1994
- Adjuvants: current status, clinical perspectives and future prospectsImmunology Today, 1993
- Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphomaNature, 1993
- Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their TumorsNew England Journal of Medicine, 1992